Using examples of drugs and companies, Dr Andreas Persidis gives tips on how to establish a systematic drug repositioning programme IP is the asset of the pharmaceutical industry. The current ...

Many companies miss opportunities to monetize their intellectual property (IP) via effectively and strategically managed approaches that generate significant additional revenue, provide competitive ...

To create a new invention is a significant accomplishment, but such achievements are often swept aside by a lack of intellectual property (IP) protections. Inventors tend to rush the build, pitch, and ...

First Nasdaq-listed company to adopt a treasury reserve strategy centered on $IP, the programmable digital asset powering the $80T intellectual property economy. As ...

“As the global economy continues to evolve toward an idea-based mindset rather than a commodities-based one, the strategic leveraging of intellectual property for raising capital presents powerful ...